Pimobendan in Chronic Right Heart Failure in a Left Ventricular Assist Device Patient
Abstract We report the case of a 76-year-old patient who developed chronic right heart failure 1 year after left ventricular assist device implantation due to ischemic cardiomyopathy. Initial recompensation was achieved through dobutamin, sildenafil, and levosimendan treatment. Yet, discharge was su...
Main Authors: | Maximilian Kreibich, Michael Berchtold-Herz, Friedhelm Beyersdorf, Georg Trummer |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2016-01-01
|
Series: | The Thoracic & Cardiovascular Surgeon Reports |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1571286 |
Similar Items
-
The effect of heart failure and left ventricular assist device treatment on right ventricular mechanics: a computational study
by: Jun I. K. Park, et al.
Published: (2018-05-01) -
Continuous‐flow left ventricular assist devices: Management in the emergency department
by: Maxwell A. Hockstein
Published: (2020-08-01) -
Beneficial aspects of real time flow measurements for the management of acute right ventricular heart failure following continuous flow ventricular assist device implantation
by: Spiliopoulos Sotirios, et al.
Published: (2012-11-01) -
Regression of severe heart failure after combined left ventricular assist device placement and sleeve gastrectomy
by: Sriram S. Nathan, et al.
Published: (2021-04-01) -
The Impact of Obesity on Left Ventricular Assist Device Outcomes
by: Konstantin Zhigalov, et al.
Published: (2020-10-01)